Abstract: The present invention provides low hygroscopic forms of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the anhydrous Aripiprazole crystals is stored for an extended period.
Abstract: The present invention relates to improved methods for purifying TGF-beta so as to obtain such in high yields. The process steps consist of acid-ethanol extracting platelets, cation exchange separation, and hydrophobic separation.